SCHEMBL23775645

SCHEMBL23775645

CCC(NC(=O)[C@@]([SiH3])(CC(C)C)NC(=O)NCc1ccccc1)C(=O)C(=O)NCc1ccc(-n2cccn2)cc1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.38
TNKS O95271 1/20 0.38
PARP1 P09874 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
NAMPT P43490 1/20 0.36
MAPK1 P28482 1/20 0.36
CTSK P43235 1/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ANPEP P15144 2/20 0.34
CAPN1 P07384 1/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23775649 0.86 CTSK (0.41) CTSKLMNAL3MBTL1ANPEPCAPN1
SCHEMBL23775476 0.84 ANPEP (0.41) CTSKL3MBTL1ANPEPCAPN1ALDH1A1
SCHEMBL23775189 0.83 CTSK (0.46) NAMPTCTSKL3MBTL1ALDH1A1KMT2A
SCHEMBL23775478 0.82 CAPN1 (0.45) CTSKANPEPCAPN1KMT2A
SCHEMBL23775642 0.81 NAMPT (0.36) NAMPTMAPK1CTSKANPEPCAPN1
SCHEMBL23775479 0.80 ANPEP (0.39) CTSKL3MBTL1ANPEPCAPN1ALDH1A1
SCHEMBL23775481 0.80 ANPEP (0.44) CTSKL3MBTL1ANPEPCAPN1ALDH1A1
SCHEMBL23775439 0.79 CAPN1 (0.41) CTSKL3MBTL1ANPEPCAPN1ALDH1A1
SCHEMBL23775483 0.79 PSMB1 (0.40) CTSKL3MBTL1ANPEPCAPN1ALDH1A1
SCHEMBL23755092 0.78 ANPEP (0.42) SCN9ATNKSPARP1TNKS2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021163631-A1 CALPAIN-2 INHIBITOR COMPOUNDS AND METHODS OF TREATMENT WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2021-08-19 WO disclosed